Study finds aspirin reduces colon cancer risk, with benefits varying by lifestyle factors

FHS
August 7, 2024
10:32 pm

Aspirin can reduce colorectal cancer risk, but its effectiveness varies based on lifestyle factors such as diet, BMI, and smoking. Personalized recommendations are crucial to identify those who would benefit most from aspirin use.

FDA expands orphan drug designation for Roswell Park’s brain cancer immunotherapy

The U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell Park

June 25, 2024

Osso VR and ACC to Develop Cardiac Procedure Training with VR

What You Should Know: – Osso VR, the leader in immersive procedural training, announces a groundbreaking collaboration with the American College of Cardiology (ACC) to

April 5, 2024

Orbitofrontal cortex holds clues for understanding and preventing depression

New research published in JCCP Advances indicates that experiencing negative life events (NLE) during childhood is linked with a higher risk of developing symptoms of

December 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.